Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03693599Phase 4Completed
Phase 4, randomised, double-blind trial of carbetocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Cairo University. Primary endpoint: Incidence of Postpartum Hemorrhage at 24 hours. Started Oct 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03693599.